A112 EARLY USE OF THERAPEUTIC DRUG MONITORING TO INDIVIDUALIZE INFLIXIMAB THERAPY IN PAEDIATRIC IBD: A MULTICENTRE PROSPECTIVE COHORT STUDY

BACKGROUND: Utilization of therapeutic drug monitoring (TDM) to individualize biologic therapy is a logical strategy, given the variable drug clearance and multiple factors influencing pharmacokinetics. Indeed, previously documented wide variability of infliximab levels have been observed early post...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Can Assoc Gastroenterol
Autors principals: Crowley, E, Carman, N J, Arpino, V, Frost, K, Ricciuto, A, Sherlock, M, Critch, J, Mack, D R, Benchimol, E I, Jacobson, K, Lawrence, S, deBruyn, J, EL-MATARY, W, Otley, A, Huynh, H Q, Church, P C, Walters, T D, Griffiths, A
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Poster Presentations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6507600/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy008.113
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars